A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®

NCT01913353 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

18-42 Year Old Healthy Vaccinia-naïve Subjects

Interventions

BIOLOGICAL: MVA BN®
BIOLOGICAL: ACAM2000®

Sponsor

Bavarian Nordic

Collaborators

[object Object]